Market Insights Health Medical Technology Medical Devices

Ophthalmic Devices - Angola

Angola

The projected revenue in the Ophthalmic Devices market market in Angola is expected to reach US$13.70m in 2024.
It is anticipated that the revenue will show an annual growth rate (CAGR 2024-2029) of 5.90%, resulting in a market volume of US$18.25m by 2029.
In global comparison, the United States is projected to generate the highest revenue in the Ophthalmic Devices market market, with US$14,000.00m in 2024.
Angola's ophthalmic devices market is experiencing a surge in demand, driven by an increasing prevalence of eye diseases and a growing awareness of the importance of eye health.

Key regions: Germany, Italy, France, Japan, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The Ophthalmic Devices market in Angola has been experiencing significant growth in recent years. Customer preferences in the Ophthalmic Devices market in Angola have been shifting towards more advanced and innovative products. This can be attributed to the increasing awareness and demand for better eye care solutions among the population. Customers in Angola are becoming more conscious about their eye health and are seeking products that can provide accurate and reliable diagnoses and treatments. As a result, there is a growing demand for ophthalmic devices with advanced features such as high-resolution imaging, automated measurements, and real-time monitoring capabilities. Trends in the Ophthalmic Devices market in Angola indicate a strong growth potential. The market is witnessing a rise in the adoption of digital ophthalmic devices, such as optical coherence tomography (OCT) scanners and digital fundus cameras. These devices offer improved diagnostic accuracy and enable healthcare professionals to detect and diagnose eye conditions at an early stage. Additionally, there is a growing demand for contact lenses and spectacle frames, driven by the increasing prevalence of vision disorders and the desire for fashionable eyewear. Local special circumstances in Angola have also contributed to the growth of the Ophthalmic Devices market. The country has a large population with a high prevalence of eye disorders, including cataracts, glaucoma, and refractive errors. This has created a significant demand for ophthalmic devices and services. However, the availability of ophthalmic devices in Angola is still limited, with many people lacking access to basic eye care. This presents an opportunity for market players to expand their presence and reach underserved areas. Underlying macroeconomic factors have also played a role in the development of the Ophthalmic Devices market in Angola. The country has been experiencing steady economic growth, which has led to an increase in disposable income and healthcare expenditure. As a result, more people are able to afford ophthalmic devices and services, driving market growth. Additionally, the government has been taking initiatives to improve healthcare infrastructure and increase access to eye care services, further supporting the growth of the Ophthalmic Devices market. Overall, the Ophthalmic Devices market in Angola is witnessing significant growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. This presents opportunities for market players to expand their presence and cater to the growing demand for advanced and innovative ophthalmic devices in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.